Skip to main content
. 2011 Oct 27;12:244. doi: 10.1186/1471-2474-12-244

Table 2.

Outcome measures at baseline and follow-up

Outcome variables Baseline
Mean (SD)
[range]
N = 63
4 Months
Mean (SD)
[range]
N = 57
8 Months
Mean (SD)
[range]
N = 55
WEST (0-4, 4 = normal) 2.77 (0.93)
[0 to 4]
3.25 (0.76)
[1 to 4]
3.37 (0.64)
[1.5 to 4]
2-PD (2 to >15 mm) 4.32 (3.00)
[2 to >15]
3.75 (3.07)
[2 to >15]
3.45 (2.82)
[2 to >15]
Locognosia (0 to 56) 45.6 (6.75)
[21 to 55]
47.9 (5.85)
[30 to 56]
48.8 (6.80)
[25 to 56]
STI Test (0 to 6, 6 = normal) 4.32 (1.74)
[0 to 6]
5.18 (1.60)
[0 to 6]
5.31 (1.39)
[0 to 6]
Grip (Newtons of force) 223.0 (92.4)
[38.7 to 452.3]
236.2 (84.2)
[98.3 to 465.3]
235.5 (91.0)
[68 to 460.1]
Pinch (Newtons of force) 59.7 (27.0)
[8.33 to 116]
63.9 (22.5)
[26 to 112.3]
63.3 (23.5)
[21.7 to 129.3]
RIHM Abduction (Newtons) 34.3 (11.7)
[7.3 to 60]
32.5 (13.2)
[0 to 59.3]
30.9 (12.4)
[7.5 to 54.4]
RIHM Opposition (Newtons) 31.6 (12.0)
[9.3 to 61.1]
31.9 (15.3)
[0 to 76]
32.7 (14.2)
[6.7 to 71.3]
BCTQ Symptoms (1 to 5, 1 = no symptoms) 2.82 (0.78) 1.71 (0.59) 1.63 (0.69)
BCTQ Function (1 to 5, 1 no difficulty) 2.19 (0.79) 1.64 (0.59) 1.63 (0.79)
Global rating of Improvement : --- 47/57 (82%) 49/56 (88%)